Andrew C. Jackson's most recent trade in Eterna Therapeutics Inc was a trade of 664,800 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 3, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc | Andrew C. Jackson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 664,800 | 664,800 | - | - | Stock Option (right to buy) |